A gene expression profile indicative of early stage HER2 targeted therapy response

被引：0
|
作者：
Fiona O’Neill
Stephen F Madden
Martin Clynes
John Crown
Padraig Doolan
Sinéad T Aherne
Robert O’Connor
机构：
[1] Dublin City University,Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology
[2] Dublin City University,School of Nursing and Human Sciences
来源：
Molecular Cancer | / 12卷
关键词：
Breast cancer; HER2 predictive markers; Targeted therapies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A gene expression profile indicative of early stage HER2 targeted therapy response
    O'Neill, Fiona
    Madden, Stephen F.
    Clynes, Martin
    Crown, John
    Doolan, Padraig
    Aherne, Sinead T.
    O'Connor, Robert
    MOLECULAR CANCER, 2013, 12
  • [2] A gene expression profile indicative of early stage HER2 tyrosine kinase inhibitor response.
    O'Neill, Fiona
    Madden, Stephen F.
    Clynes, Martin
    Doolan, Padraig
    Crown, John
    Aherne, Sinead
    O'Connor, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] HER2 expression as a potential marker for response to therapy targeted to the EGFR
    Emlet, DR
    Schwartz, R
    Brown, KA
    Pollice, AA
    Smith, CA
    Shackney, SE
    BRITISH JOURNAL OF CANCER, 2006, 94 (08) : 1144 - 1153
  • [4] HER2 expression as a potential marker for response to therapy targeted to the EGFR
    D R Emlet
    R Schwartz
    K A Brown
    A A Pollice
    C A Smith
    S E Shackney
    British Journal of Cancer, 2006, 94 : 1144 - 1153
  • [5] HER2 targeted therapy: Determinants of response and mechanisms of resistance
    Schiff, R.
    Veeraraghavan, J.
    De Angelis, C.
    Osborne, C.
    Rimawi, M. F.
    CANCER RESEARCH, 2021, 81 (04)
  • [6] Her2 a paradigm for targeted therapy
    Marijon, Helene
    Andre, Fabrice
    BULLETIN DU CANCER, 2011, 98 (09) : 1011 - 1017
  • [7] Development of HER2 targeted therapy
    Tamura, Kenji
    CANCER SCIENCE, 2021, 112 : 158 - 158
  • [8] Alternative targeted therapy for early Her2 positive breast cancer
    Harvey, Sandra L.
    Khasraw, Mustafa
    GLAND SURGERY, 2013, 2 (01) : 42 - 45
  • [9] Perioperative HER2 targeted treatment in early stage HER2-positive breast cancer
    Hong, Joohyun
    Park, Yeon Hee
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [10] Association between HER2 positivity by HER2/CEP17 ratio and response to neoadjuvant HER2 targeted therapy.
    Rappazzo, Katherine Cynthia
    Chen, Heidi
    Ballinger, Tarah Jean
    Abramson, Vandana Gupta
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345